Metraipolis › archive › dc_09411348f269
Comparative clinical outcomes and safety of finerenone, SGLT2 inhibitors, RAS inhibitors and ARNI in heart failure with preserved or mildly reduced ejection… — Europe PMC PMID:42222151
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42222151
- DOI
- 10.3389/fphar.2026.1813205
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T16:27:44.246Z
- SHA-256 of the archived text
68f6ca7dc24679980175eed22324ed98da24608f8fdf943e359f44a4872b1efe- Stable URL of this page
https://metraipolis.com/documento/dc_09411348f269
How to cite
Comparative clinical outcomes and safety of finerenone, SGLT2 inhibitors, RAS inhibitors and ARNI in heart failure with preserved or mildly reduced ejection… — Europe PMC PMID:42222151 — Europe PMC (en), https://europepmc.org/article/MED/42222151 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_09411348f269 (Metraipolis archive dc_09411348f269, sha256 68f6ca7dc24679980175eed22324ed98da24608f8fdf943e359f44a4872b1efe)
BibTeX
@misc{dc09411348f269,
title = {Comparative clinical outcomes and safety of finerenone, SGLT2 inhibitors, RAS inhibitors and ARNI in heart failure with preserved or mildly reduced ejection… — Europe PMC PMID:42222151},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42222151},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_09411348f269; sha256 68f6ca7dc24679980175eed22324ed98da24608f8fdf943e359f44a4872b1efe},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42222151. Agents can read the archived copy with the MCP tool read_document.